SEVERE HYPERTRIGLYCERIDEMIA
Clinical trials for SEVERE HYPERTRIGLYCERIDEMIA explained in plain language.
Never miss a new study
Get alerted when new SEVERE HYPERTRIGLYCERIDEMIA trials appear
Sign up with your email to follow new studies for SEVERE HYPERTRIGLYCERIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection aims to tame dangerous blood fats
Disease control OngoingThis study is testing whether a new injectable drug called plozasiran can safely and effectively lower very high levels of triglycerides (a type of fat) in the blood. About 446 adults with severe hypertriglyceridemia will receive either the drug or a placebo injection every three…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
3-Year safety check for promising triglyceride drug
Disease control OngoingThis study aims to check the long-term safety of the drug olezarsen in people with severely high triglycerides. It follows about 800 patients from two earlier trials for up to 3 years of treatment. The main goal is to see if the drug causes any side effects or health problems ove…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New injection aims to tame dangerous blood fats
Disease control OngoingThis study is testing whether a new injectable drug called plozsiran can safely and effectively lower very high levels of triglycerides (a type of fat) in the blood. About 311 adults with severe hypertriglyceridemia will receive either the drug or a placebo injection every three …
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC